Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT05620407

Public ClinicalTrials.gov record NCT05620407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)

Study identification

NCT ID
NCT05620407
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
513 participants

Conditions and interventions

Interventions

  • Deucravacitinib Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2023
Primary completion
Oct 18, 2026
Completion
Nov 12, 2028
Last update posted
Dec 1, 2025

2023 – 2028

United States locations

U.S. sites
39
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Local Institution - 0063 La Jolla California 92037
Local Institution - 0241 La Mesa California 91942
Local Institution - 0242 San Diego California 92128
Local Institution - 0143 San Leandro California 94578
Local Institution - 0147 Santa Monica California 90404
Local Institution - 0213 Clearwater Florida 33765
Local Institution - 0059 Jacksonville Florida 32256
Local Institution - 0075 Margate Florida 33063
Local Institution - 0007 Oakland Park Florida 33334
Local Institution - 0239 Plant City Florida 33160
Emory University School of Medicine- Grady Campus Atlanta Georgia 30303
Local Institution - 0137 Marietta Georgia 30060
Local Institution - 0089 Orland Park Illinois 60467
Local Institution - 0041 Skokie Illinois 60076
Local Institution - 0231 New Orleans Louisiana 70112
Local Institution - 0060 Boston Massachusetts 02114
Local Institution - 0056 Boston Massachusetts 02215
Local Institution - 0084 Worcester Massachusetts 01605
Local Institution - 0152 Grand Blanc Michigan 48439
Local Institution - 0072 Rochester Minnesota 55905
Local Institution - 0216 Las Vegas Nevada 89102
Local Institution - 0165 Paramus New Jersey 07652
Local Institution - 0069 Brooklyn New York 11201
Local Institution - 0217 Great Neck New York 11021
Local Institution - 0150 New York New York 10021
Local Institution - 0102 New York New York 10032
Local Institution - 0145 Syracuse New York 13210
Local Institution - 0178 Charlotte North Carolina 28210
Local Institution - 0005 Cleveland Ohio 44106
Local Institution - 0043 Oklahoma City Oklahoma 73104
Local Institution - 0205 Pittsburgh Pennsylvania 15224
Local Institution - 0081 Charleston South Carolina 29425
Local Institution - 0225 Florence South Carolina 29501
Local Institution - 0002 Jackson Tennessee 38305
Local Institution - 0001 Colleyville Texas 76034
Local Institution - 0164 El Paso Texas 79902
Local Institution - 0169 Katy Texas 77494
Local Institution - 0201 Temple Texas 76508
Local Institution - 0133 Danville Virginia 24541

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05620407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 1, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05620407 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →